Image
graphic of a COVID  spike cell and DNA strand
Type
ELSIhub Collections
Date

ELSIhub Collections | Ethical, Legal, and Social Implications (ELSI) at the Intersection of Genomics and Infectious Disease

Click here for all ELSIhub Collections

Collection Editors

Debra JH Mathews, PhD, MA, Center for Bridging Infectious Disease, Genomics, and Society (BRIDGES), Assistant Director for Science Programs at the Berman Institute of Bioethics and Associate Professor of Genetic Medicine at Johns Hopkins University

Sheethal Jose, PhD Student in Bioethics and Health Policy, Center for Bridging Infectious Disease, Genomics, and Society (BRIDGES), Johns Hopkins Berman Institute of Bioethics and the Bloomberg School of Public Health

Introduction

Scientific and technological advances in the field of genomics have the potential to enable targeted clinical and public health measures to manage infectious disease outbreaks. The convergence of the fields of genomics and public health in the context of infectious disease raises a unique constellation of ethical, legal, and social issues that must be addressed before genomic data and technology are leveraged at the population level. Similarly, both pathogen genomics and host (or human) genomics play a role in the clinical management of infectious disease and raise their own ELSI issues. The COVID-19 pandemic, coupled with advances in genomic sequencing technology, has provided a global laboratory for identifying, for example, host genomic factors that influence an individual’s risk of severe COVID-19 disease. The identification of such factors has implications for both clinical management and public health practice.

While not an exhaustive list, this collection provides an introduction to the ELSI literature at the intersection of genomics and infectious diseases in both the clinical and public health contexts. The articles listed below focus primarily on the examples of SARS-CoV-2/COVID-19 and HIV/AIDS, but the ELSI issues raised are applicable across the infectious disease spectrum. The first set of articles provides historical context for the concept of disease causation and the blurring boundary between infectious and genetic diseases. The next two groups of articles focus on the different ELSI issues raised by host genomics (using the example of COVID-19) and pathogen genomics (using the example of HIV), respectively, in research, clinical, and public health contexts. The fourth set of articles provides a glimpse into the history of race and racism in both genomics and infectious disease and highlights the critical need for viewing the ELSI issues raised at this intersection through a health disparities lens. Lastly, the fifth group of articles attempts to provide concrete ways of addressing these ELSI issues and identifies areas for further research.

Historical Pandemic Response and the Evolution of the Understanding of Disease Causation
The Intersection of Host Genomics and Infectious Diseases with a Focus on SARS-CoV-2/COVID-19
Pathogen Genomics with a Focus on HIV/AIDS
Racism, Genomics, and Infectious Disease
Conceptual and Empirical Responses to the Blurring Boundary

Tags

Share